New frontiers in CRISPR: Addressing antimicrobial resistance with Cas9, Cas12, Cas13, and Cas14
Background: The issue of antimicrobial resistance (AMR) poses a major challenge to global health, evidenced by alarming mortality predictions and the diminishing efficiency of conventional antimicrobial drugs. The CRISPR-Cas system has proven to be a powerful tool in addressing this challenge. It or...
Saved in:
| Main Authors: | Ahmed S.A. Ali Agha, Ali Al-Samydai, Talal Aburjai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025003937 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of CRISPR-Cas9, CRISPR-Cas12f1, and CRISPR-Cas3 in eradicating resistance genes KPC-2 and IMP-4
by: Jun Huang, et al.
Published: (2025-06-01) -
Advancements in CRISPR/Cas systems for disease treatment
by: Yangsong Xu, et al.
Published: (2025-06-01) -
Parallel and Visual Detections of ASFV by CRISPR-Cas12a and CRISPR-Cas13a Systems Targeting the Viral S273R Gene
by: Hongjian Han, et al.
Published: (2025-06-01) -
The CRISPR/Cas system: Gene Editing by bacterial defense
by: Amira H. El-Ashry
Published: (2023-09-01) -
Precisely Targeted Nanoparticles for CRISPR-Cas9 Delivery in Clinical Applications
by: Xinmei Liu, et al.
Published: (2025-04-01)